Identification of disulfide cross-linked tau dimer responsible for tau propagation

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kim, Dohee ^a,b   Lim, Sungsu ^a   Haque, Md Mamunul ^a,c   Ryoo, Nayeon ^a   Hong, Hyun Seok ^d   Rhim, Hyewhon ^a,c   Lee, Dong Eun ^e   Chang, Young Tae ^f,g   Lee, Jun Seok ^a,c   Cheong, Eunji ^b   Kim, Dong Jin ^a   Kim, Yun Kyung ^a,c  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Medifron DBT Inc   (South Korea)

^e Korea Atomic Energy Research Institute   (South Korea)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; TAU PROTEIN;

ANIMAL; BRAIN; CELL CULTURE; CHEMISTRY; CYTOLOGY; DIMERIZATION; FLUORESCENCE MICROSCOPY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOUSE; MUTAGENESIS; NERVE CELL; PATHOLOGY; RAT; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; BRAIN; CELLS, CULTURED; DIMERIZATION; DISULFIDES; HEK293 CELLS; HUMANS; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MUTAGENESIS; NEURONS; RATS; TAU PROTEINS;

EID: 84944339538     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep15231     Document Type: Article

References (28)

1. Kolarova, M. et al. Structure and pathology of tau protein in Alzheimer disease. International journal of Alzheimer's disease 2012, 731526 (2012).
2. Johnson, G. V. & Hartigan, J. A. Tau protein in normal and Alzheimer's disease brain: an update. J. Alzheimers Dis. 1, 329-351 (1999).
3. Brunden, K. R., Trojanowski, J. Q. & Lee, V. M.-Y. Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J. Alzheimers Dis. 14, 393-399 (2008).
4. Lee, G. & Leugers, C. J. Tau and tauopathies. Prog. Mol. Biol. Transl. 107, 263-293 (2012).
5. Clavaguera, F. et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. PNAS 110, 9535-9540 (2013).
6. Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913 (2009).
7. Guo, J. L. & Lee, V. M. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J. Biol. Chem. 286, 15317-15331 (2011).
8. Guo, J. L. & Lee, V. M. Neurofibrillary tangle-like tau pathology induced by synthetic tau fibrils in primary neurons overexpressing mutant tau. FEBS Lett. 587, 717-723 (2013).
9. Iba, M. et al. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy. J. Neurosci. 33, 1024-1037 (2013).
10. Pooler, A. M. et al. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. 14, 389-394 (2013).
11. Saman, S. et al. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J. Biol. Chem. 287, 3842-3849 (2012).
12. Wu, J. W. et al. Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J. Biol. Chem. 288, 1856-1870 (2013).
13. Lasagna-Reeves, C. A. et al. Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau. Sci. Rep. 2, 700 (2012).
14. Pooler, A. M. et al. Propagation of tau pathology in Alzheimer's disease: identification of novel therapeutic targets. Alzheimer Res. Ther. 5, 49 (2013).
15. Tak, H. et al. Bimolecular fluorescence complementation; lighting-up tau-tau interaction in living cells. PloS one 8, e81682 (2013).
16. Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F. & Berry, R. W. Tau, tangles, and Alzheimer's disease. Biochim. Biophys. Acta 1739, 216-223 (2005).
17. Frost, B., Jacks, R. L. & Diamond, M. I. Propagation of tau misfolding from the outside to the inside of a cell. J. Biol. Chem. 284, 12845-12852 (2009).
18. Arrasate, M., Perez, M., Armas-Portela, R. & Avila, J. Polymerization of tau peptides into fibrillar structures. The effect of FTDP-17 mutations. FEBS Lett. 446, 199-202 (1999).
19. Haque, M. M. et al. Inhibition of tau aggregation by a rosamine derivative that blocks tau intermolecular disulfide cross-linking. Amyloid 21, 185-190 (2014).
20. Ksiezak-Reding, H. & Wall, J. S. Characterization of paired helical filaments by scanning transmission electron microscopy. Microsc. Res. Tech. 67, 126-140 (2005).
21. Walker, S., Ullman, O. & Stultz, C. M. Using intramolecular disulfide bonds in tau protein to deduce structural features of aggregation-resistant conformations. J. Biol. Chem. 287, 9591-9600 (2012).
22. Er, J. C. et al. NeuO: a Fluorescent Chemical Probe for Live Neuron Labeling. Angew. Chem. Int. Ed. 54, 2442-2446 (2015).
23. Lewis, J. et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25, 402-405 (2000).
24. Ahmed, Z. et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 127, 667-683 (2014).
25. Yamada, K. et al. In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J. Neurosci. 31, 13110-13117 (2011).
26. Shammas, S. L. et al. A mechanistic model of tau amyloid aggregation based on direct observation of oligomers. Nat. Commun. 6, 7025 (2015).
27. Zhao, Y. Z. & Zhao, B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid. Med. Cell Longev. 2013, 316523 (2013).
28. Franklin, K. B. & Paxinos, G. Mouse brain in stereotaxic coordinates, 2nd edn (Academic press, 1997).